INmune Bio, Inc. INMB
NASDAQ · United States · Health Technology
$1.930.00 (0.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.05 | -0.21 | +75.8% | $0 | — | +9.7%$1.90→$2.09 |
| Q4 2025 | 2026-03-30 | -0.18 | -0.27 | +33.3% | — | — | +0.9%$1.12→$1.13 |
| Q4 2024 | 2025-03-27 | -0.40 | -0.53 | +24.5% | — | — | — |
| Q4 2023 | 2024-03-28 | -0.47 | -0.46 | -2.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.